Literature DB >> 15794783

Correlation between clinical and pathological staging in a series of radical cystectomies for bladder carcinoma.

Vincenzo Ficarra1, Orietta Dalpiaz, Najati Alrabi, Giacomo Novara, Antonio Galfano, Walter Artibani.   

Abstract

OBJECTIVE: To analyse the rate of concordance between the clinical and pathological Tumour-Nodes-Metastasis staging systems in a homogeneous series of patients who had undergone radical cystectomy for locally advanced or recurrent multifocal superficial bladder carcinoma. PATIENTS AND METHODS: The clinical data of 156 patients who had undergone radical cystectomy and bilateral iliaco-obturator lymphadenectomy for bladder cancer in our department were analysed retrospectively. RESULTS The clinical stage of the primary tumour was carcinoma in situ in three patients (1.9%), cT1 in 67 (42.9%), cT2 in 70 (44.9%), cT3 in five (3.2%) and cT4 in nine (5.8%). Clinical lymph node involvement was detected in 19 patients (12.2%). The differences between clinical and pathological stages were statistically significant (P < 0.001), the concordance was moderate (kappa = 0.27, P < 0.001). Of the 70 patients with < or = cT1, 40 (57%) were reconfirmed as having pathological stage < or = T1; of the 70 with cT2, 16 (23%) had pT2 carcinoma. Of the 140 patients with clinically organ-confined (< or =T2) neoplasms, 70 (50%) had been understaged after radical cystectomy. The clinical and pathological systems were statistically overlapping for locally advanced cases only. Pathological lymph node involvement was diagnosed in 45 patients (28.8%); this was foreseen with pelvic computed tomography in 19 (12%) only (P < 0.001). All patients designated cN+ were also pN+.
CONCLUSION: These data confirm the high risk of clinical understaging of both local extension of the primary tumour and lymph node involvement.

Entities:  

Mesh:

Year:  2005        PMID: 15794783     DOI: 10.1111/j.1464-410X.2005.05401.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  36 in total

1.  [Radical cystectomy in the treatment of bladder cancer always in due time?].

Authors:  M May; K-P Braun; W Richter; C Helke; H Vogler; B Hoschke; M Siegsmund
Journal:  Urologe A       Date:  2007-08       Impact factor: 0.639

2.  Comparative sensitivity and specificity of imaging modalities in staging bladder cancer prior to radical cystectomy: a systematic review and meta-analysis.

Authors:  Jack Crozier; Nathan Papa; Marlon Perera; Brian Ngo; Damien Bolton; Shomik Sengupta; Nathan Lawrentschuk
Journal:  World J Urol       Date:  2018-08-17       Impact factor: 4.226

3.  Downstaging to non-invasive urothelial carcinoma is associated with improved outcome following radical cystectomy for patients with cT2 disease.

Authors:  Matthew K Tollefson; Stephen A Boorjian; Sara A Farmer; Igor Frank
Journal:  World J Urol       Date:  2012-03-25       Impact factor: 4.226

4.  Evaluating the utility of a preoperative nomogram for predicting 90-day mortality following radical cystectomy for bladder cancer.

Authors:  Jennifer M Taylor; Andrew Feifer; Caroline J Savage; Alexandra C Maschino; Melanie Bernstein; Harry W Herr; S Machele Donat
Journal:  BJU Int       Date:  2011-07-01       Impact factor: 5.588

5.  Influence of preoperative hydronephrosis and ureteral orifice involvement in the survival of patients undergoing radical cystectomy: A retrospective comparative study.

Authors:  Ertuğrul Şefik; Serdar Çelik; Bülent Günlüsoy; İsmail Basmacı; Serkan Yarımoğlu; İbrahim Halil Bozkurt; Tansu Değirmenci; Çetin Dinçel
Journal:  Turk J Urol       Date:  2019-04-03

6.  Impact of concomitant carcinoma in situ on upstaging and outcome following radical cystectomy for bladder cancer.

Authors:  Faysal A Yafi; Armen G Aprikian; Joseph L Chin; Yves Fradet; Jonathan Izawa; Eric Estey; Adrian Fairey; Ricardo Rendon; Ilias Cagiannos; Louis Lacombe; Jean-Baptiste Lattouf; Fred Saad; David Bell; Darrel Drachenberg; Wassim Kassouf
Journal:  World J Urol       Date:  2013-11-10       Impact factor: 4.226

Review 7.  Use of nomograms as predictive tools in bladder cancer.

Authors:  Ahmad Shabsigh; Bernard H Bochner
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

8.  Natural history of pT3-4 or node positive bladder cancer treated with radical cystectomy and no neoadjuvant chemotherapy in a contemporary North-American multi-institutional cohort.

Authors:  Nicholas E Power; Wassim Kassouf; David Bell; Armen G Aprikian; Yves Fradet; Louis Lacombe; Joseph Chin; Jonathan Izawa; Eric Estey; Adrian Fairey; Ilias Cagiannos; Jean-Baptiste Lattouf; Darrel Drachenberg; Ricardo A Rendon
Journal:  Can Urol Assoc J       Date:  2012-12       Impact factor: 1.862

Review 9.  Practical use of perioperative chemotherapy for muscle-invasive bladder cancer: summary of session at the Society of Urologic Oncology annual meeting.

Authors:  Andrea B Apolo; Herbert Barton Grossman; Dean Bajorin; Gary Steinberg; Ashish M Kamat
Journal:  Urol Oncol       Date:  2012 Nov-Dec       Impact factor: 3.498

10.  Targeted therapies in the management of metastatic bladder cancer.

Authors:  Matteo Fassan; Edouard J Trabulsi; Leonard G Gomella; Raffaele Baffa
Journal:  Biologics       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.